2018-2020 Issue Discussion Topics
The Issue Discussion Topics for the 2018-2020 Conference Cycle are: Carrying the NA Message and Making NA Attractive, Attracting Members to Service, and Drug Replacement Therapy (DRT) and Medically Assisted Treatment (MAT) and NA. The material for each of these topics will be updated during the conference cycle, so check back often. Please submit your input to worldboard@na.org.
____________________________________________________________________________________________
Carrying the NA Message and Making NA Attractive
English
Session Profiles: PDF | DOC | Session Notes | PowerPoint Presentation
Spanish
Session Profiles: PDF | DOC | Session Notes | PowerPoint Presentation
Russian
Session Profiles: PDF | Session Notes | PowerPoint Presentation
____________________________________________________________________________________________
Attracting Members to Service
English
Session Profiles: PDF | DOC | Session Notes | PowerPoint Presentation
NA Service System Diagram | Vision Statement
Spanish
Session Profiles: PDF | DOC | Session Notes | PowerPoint Presentation
NA Service System Diagram | Vision Statement
Russian
Session Profiles: PDF | Session Notes | PowerPoint Presentation
NA Service System Diagram | Vision Statement
____________________________________________________________________________________________
Drug Replacement Therapy (DRT) and
Medication Assisted Treatment (MAT) as it relates to NA
Medication Assisted Treatment (MAT) as it relates to NA
English
Session Profiles: PDF | DOC | PowerPoint Presentation
Session Notes | Session Notes with No Quotes
Spanish
Session Profiles: PDF | DOC | Session Notes | PowerPoint Presentation
Russian
Session Profiles: PDF | Session Notes | PowerPoint Presentation
News for the Public
Contains links to items of interest to the general public and professionals about the Fellowship of Narcotics Anonymous
Please contact the webmaster if you have any comments, are not able to find something that you are looking for, or have any questions about the web site.
SUBSCRIBEto our Periodicals and Other Publications